Phase II evaluation of the AMAP, 773U82 mesylate, in pancreatic cancer

Donald L. Trump, James A. Hathorn, Louise B. Grochow, David Spriggs, Melody L. Eble, John A. Hohneker

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Phase II evaluation of the AMAP, 773U82 mesylate, in pancreatic cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences